|
上海復旦張江生物醫藥股份有限公司 - H股, 01349.HK - 綜合現金流量表 |
2022-12 |
2021-12 |
2020-12 |
2019-12 |
2018-12 |
2017-12 |
2016-12 |
2015-12 |
2014-12 |
2013-12 |
2012-12 |
2011-12 |
2010-12 |
2009-12 |
2008-12 |
經營活動之現金流量 |
233,929 |
337,018 |
179,091 |
378,966 |
268,853 |
66,637 |
163,166 |
115,568 |
106,223 |
107,084 |
123,565 |
53,461 |
-4,709 |
9,863 |
-14,866 |
投資回報及融資費用之現金流量 |
-71,039 |
-52,150 |
-69,766 |
-70,198 |
-34,181 |
-50,153 |
-28,275 |
-50,064 |
-1,006 |
-3,483 |
-5,261 |
-3,872 |
-2,399 |
-2,139 |
-897 |
已收利息 |
0 |
0 |
0 |
0 |
0 |
2,076 |
3,773 |
2,919 |
864 |
1,957 |
905 |
990 |
547 |
406 |
586 |
已付利息 |
0 |
0 |
0 |
0 |
0 |
-6,079 |
-4,062 |
-7,129 |
-1,870 |
-5,440 |
-6,166 |
-4,862 |
-2,946 |
-2,545 |
-1,483 |
已收股息 |
0 |
0 |
0 |
0 |
-34,181 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
已付股息 |
-71,039 |
-52,150 |
-69,766 |
-70,198 |
0 |
-46,150 |
-27,986 |
-45,854 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
其他 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
退回/(已繳)稅項 |
-68,660 |
-68,118 |
-66,087 |
-109,734 |
-89,015 |
-19,923 |
-22,303 |
-15,062 |
-16,858 |
-14,159 |
-8,116 |
0 |
0 |
0 |
0 |
投資活動之現金流量 |
-96,748 |
-355,671 |
-46,535 |
-21,142 |
-48,037 |
-64,565 |
-47,197 |
-61,872 |
-42,189 |
-58,555 |
-114,928 |
-35,155 |
2,185 |
-50,993 |
-1,109 |
增添固定資產 |
-87,304 |
-120,116 |
-42,411 |
-40,386 |
-38,963 |
-55,444 |
-46,273 |
-38,250 |
-44,089 |
-56,716 |
-114,605 |
-32,988 |
-9,406 |
-55,791 |
-2,916 |
出售固定資產 |
1,442 |
1,706 |
12,026 |
2,618 |
2,248 |
1,153 |
586 |
2,233 |
545 |
1,232 |
36 |
14 |
11,312 |
27 |
29 |
投資增加 |
0 |
-265,959 |
-36,000 |
0 |
-24,000 |
-1,620,660 |
-1,295,550 |
-1,790,215 |
-1,411,817 |
-422,400 |
-4,757 |
-3,422 |
-7,868 |
-6,568 |
-10,627 |
投資減少 |
0 |
6,340 |
0 |
6,796 |
0 |
1,619,105 |
1,302,133 |
1,776,817 |
1,418,590 |
424,552 |
5,669 |
4,437 |
8,147 |
11,364 |
6,199 |
與關聯人士之現金流量 |
0 |
0 |
0 |
0 |
12,294 |
5,165 |
4,990 |
11,630 |
0 |
0 |
3,100 |
0 |
0 |
68,816 |
30,000 |
其他 |
-10,886 |
22,358 |
19,850 |
9,830 |
384 |
-13,884 |
-13,083 |
-24,087 |
-5,418 |
-5,223 |
-4,371 |
-3,196 |
0 |
-68,841 |
-23,794 |
融資活動前之現金流量 |
-2,518 |
-138,921 |
-3,298 |
177,893 |
97,620 |
-68,004 |
65,391 |
-11,430 |
46,170 |
30,887 |
-4,740 |
14,434 |
-4,923 |
-43,269 |
-16,872 |
融資活動之現金流量 |
82,647 |
-49,014 |
823,613 |
-189,372 |
22,294 |
25,165 |
-10 |
101,330 |
-15,000 |
135,773 |
52,938 |
5,330 |
8,330 |
80,816 |
40,000 |
新增貸款 |
101,000 |
0 |
51,057 |
151,568 |
150,000 |
140,000 |
180,000 |
185,000 |
0 |
15,000 |
96,998 |
60,000 |
27,000 |
32,000 |
10,000 |
償還貸款 |
0 |
0 |
-200,000 |
-150,000 |
-140,000 |
-120,000 |
-185,000 |
-95,300 |
-15,000 |
-101,498 |
-47,160 |
-54,670 |
-18,670 |
-20,000 |
0 |
定息/債項工具融資 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
償還定息/債項工具 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
股本融資 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
222,271 |
0 |
0 |
0 |
0 |
0 |
與關聯人士之現金流量 |
0 |
0 |
0 |
0 |
12,294 |
5,165 |
4,990 |
11,630 |
0 |
0 |
3,100 |
0 |
0 |
68,816 |
30,000 |
其他 |
-18,353 |
-49,014 |
972,556 |
-190,940 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
現金及等同現金之增加/(減少) |
80,129 |
-187,935 |
820,315 |
-11,478 |
119,914 |
-42,839 |
65,381 |
89,900 |
31,170 |
166,660 |
48,198 |
19,764 |
3,407 |
37,547 |
23,128 |
年初之現金及現金等同項目 |
1,208,881 |
1,396,890 |
576,799 |
588,221 |
468,143 |
511,284 |
445,997 |
356,097 |
324,927 |
158,267 |
110,069 |
90,305 |
86,898 |
49,351 |
26,280 |
外匯兌換率變動之影響/(其他) |
293 |
-74 |
-224 |
56 |
164 |
-301 |
-94 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
-57 |
年終之現金及現金等同項目 |
1,289,303 |
1,208,881 |
1,396,890 |
576,799 |
588,221 |
468,144 |
511,284 |
445,997 |
356,097 |
324,927 |
158,267 |
110,069 |
90,305 |
86,898 |
49,351 |
貨幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
單位 |
千 |
千 |
千 |
千 |
核數師意見 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
說明:1代表無保留意見;2代表保留意見;3代表修改意見
|
|